Igenica Biotherapeutics, Inc. Email Format
BiotechnologyCalifornia, United States11-50 Employees
Igenica Biotherapeutics, Inc. is a biotechnology company focused on discovering antibody-based therapies for cancer. Its integrated discovery platform is used to build a pipeline of immunotherapies and antibody-drug conjugates intended to address cancer patients' needs. The company operates within the biotechnology research sector and is based in Burlingame, California. The organization is small-to-mid-sized. In 2013, Igenica announced the appointment of Thi-Sau Migone as Chief Scientific Officer.